The historic rise of Viagra has long been a benchmark of pharmaceutical success, yet its position within the broader market now triggers questions about long-term returns . Generic versions are diminishing https://bookmarkity.com/story21586399/the-blue-diamond-and-drug-companies-a-uncertain-opportunity